PIK3CA c.1598C>T ;(p.A533V)

Variant ID: 3-178936056-C-T

NM_006218.2(PIK3CA):c.1598C>T;(p.A533V)

This variant was identified in 8 publications

View GRCh38 version.




Publications:


Integrative genomic and transcriptomic analyses illuminate the ontology of HER2-low breast carcinomas.

Genome Medicine
Berrino, Enrico E; Annaratone, Laura L; Bellomo, Sara Erika SE; Ferrero, Giulio G; Gagliardi, Amedeo A; Bragoni, Alberto A; Grassini, Dora D; Guarrera, Simonetta S; Parlato, Caterina C; Casorzo, Laura L; Panero, Mara M; Sarotto, Ivana I; Giordano, Silvia S; Cereda, Matteo M; Montemurro, Filippo F; Ponzone, Riccardo R; Crosetto, Nicola N; Naccarati, Alessio A; Sapino, Anna A; MarchiĆ², Caterina C
Publication Date: 2022-08-29

Variant appearance in text: PIK3CA: 1598C>T
PubMed Link: 36038884
Variant Present in the following documents:
  • 13073_2022_1104_MOESM10_ESM.xlsx, sheet 1
View BVdb publication page



GPCR-mediated PI3K pathway mutations in pediatric and adult thyroid cancer.

Oncotarget
Murugan, Avaniyapuram Kannan AK; Qasem, Ebtesam E; Al-Hindi, Hindi H; Alzahrani, Ali S AS
Publication Date: 2019-06-25

Variant appearance in text: PIK3CA: A533V
PubMed Link: 31289610
Variant Present in the following documents:
  • Main text
  • oncotarget-10-4107.pdf
View BVdb publication page



Formalin fixation increases deamination mutation signature but should not lead to false positive mutations in clinical practice.

Plos One
Prentice, Leah M LM; Miller, Ruth R RR; Knaggs, Jeff J; Mazloomian, Alborz A; Aguirre Hernandez, Rosalia R; Franchini, Patrick P; Parsa, Kourosh K; Tessier-Cloutier, Basile B; Lapuk, Anna A; Huntsman, David D; Schaeffer, David F DF; Sheffield, Brandon S BS
Publication Date: 2018

Variant appearance in text: PIK3CA: A533V
PubMed Link: 29698444
Variant Present in the following documents:
  • pone.0196434.s001.xlsx, sheet 2
  • pone.0196434.s001.xlsx, sheet 3
View BVdb publication page



Characterization of PIK3CA and PIK3R1 somatic mutations in Chinese breast cancer patients.

Nature Communications
Chen, Li L; Yang, Liu L; Yao, Ling L; Kuang, Xia-Ying XY; Zuo, Wen-Jia WJ; Li, Shan S; Qiao, Feng F; Liu, Yi-Rong YR; Cao, Zhi-Gang ZG; Zhou, Shu-Ling SL; Zhou, Xiao-Yan XY; Yang, Wen-Tao WT; Shi, Jin-Xiu JX; Huang, Wei W; Hu, Xin X; Shao, Zhi-Ming ZM
Publication Date: 2018-04-10

Variant appearance in text: PIK3CA: A533V
PubMed Link: 29636477
Variant Present in the following documents:
  • 41467_2018_Article_3867.pdf
  • 41467_2018_3867_MOESM1_ESM.pdf
View BVdb publication page



Circulating tumour DNA sequence analysis as an alternative to multiple myeloma bone marrow aspirates.

Nature Communications
Kis, Olena O; Kaedbey, Rayan R; Chow, Signy S; Danesh, Arnavaz A; Dowar, Mark M; Li, Tiantian T; Li, Zhihua Z; Liu, Jessica J; Mansour, Mark M; Masih-Khan, Esther E; Zhang, Tong T; Bratman, Scott V SV; Oza, Amit M AM; Kamel-Reid, Suzanne S; Trudel, Suzanne S; Pugh, Trevor J TJ
Publication Date: 2017-05-11

Variant appearance in text: PIK3CA: A533V
PubMed Link: 28492226
Variant Present in the following documents:
  • ncomms15086-s3.xlsx, sheet 1
View BVdb publication page



PIK3CA mutations are associated with reduced pathological complete response rates in primary HER2-positive breast cancer: pooled analysis of 967 patients from five prospective trials investigating lapatinib and trastuzumab.

Annals Of Oncology : Official Journal Of The European Society For Medical Oncology
Loibl, S S; Majewski, I I; Guarneri, V V; Nekljudova, V V; Holmes, E E; Bria, E E; Denkert, C C; Schem, C C; Sotiriou, C C; Loi, S S; Untch, M M; Conte, P P; Bernards, R R; Piccart, M M; von Minckwitz, G G; Baselga, J J
Publication Date: 2016-08

Variant appearance in text: PIK3CA: A533V
PubMed Link: 27177864
Variant Present in the following documents:
  • Main text
View BVdb publication page



Erlotinib, erlotinib-sulindac versus placebo: a randomized, double-blind, placebo-controlled window trial in operable head and neck cancer.

Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research
Gross, Neil D ND; Bauman, Julie E JE; Gooding, William E WE; Denq, William W; Thomas, Sufi M SM; Wang, Lin L; Chiosea, Simion S; Hood, Brian L BL; Flint, Melanie S MS; Sun, Mai M; Conrads, Thomas P TP; Ferris, Robert L RL; Johnson, Jonas T JT; Kim, Seungwon S; Argiris, Athanassios A; Wirth, Lori L; Nikiforova, Marina N MN; Siegfried, Jill M JM; Grandis, Jennifer R JR
Publication Date: 2014-06-15

Variant appearance in text: PIK3CA: 1598C>T; A533V
PubMed Link: 24727329
Variant Present in the following documents:
  • Main text
View BVdb publication page



Predicting the functional impact of protein mutations: application to cancer genomics.

Nucleic Acids Research
Reva, Boris B; Antipin, Yevgeniy Y; Sander, Chris C
Publication Date: 2011-09-01

Variant appearance in text: PIK3CA: A533V
PubMed Link: 21727090
Variant Present in the following documents:
  • supp_gkr407_Supplement2_Table_SM1_COSMIC_mutations.xls, sheet 1
View BVdb publication page